The World Health Organization said it strongly recommended the Pfizer antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation
Geneva, Switzerland: The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
However the UN agency warned it was "extremely concerned" that the inequality in access seen with Covid vaccines would again leave low- and middle-income countries "pushed to the end of the queue".